[go: up one dir, main page]

ES498941A0 - Procedimiento para obtener relaxina humana - Google Patents

Procedimiento para obtener relaxina humana

Info

Publication number
ES498941A0
ES498941A0 ES498941A ES498941A ES498941A0 ES 498941 A0 ES498941 A0 ES 498941A0 ES 498941 A ES498941 A ES 498941A ES 498941 A ES498941 A ES 498941A ES 498941 A0 ES498941 A0 ES 498941A0
Authority
ES
Spain
Prior art keywords
procedure
obtaining human
human relaxin
relaxin
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES498941A
Other languages
English (en)
Other versions
ES8203914A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Argentina SA
Original Assignee
Serono Argentina SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Argentina SA filed Critical Serono Argentina SA
Publication of ES498941A0 publication Critical patent/ES498941A0/es
Publication of ES8203914A1 publication Critical patent/ES8203914A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES498941A 1980-02-01 1981-01-29 Procedimiento para obtener relaxina humana Expired ES8203914A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/117,444 US4267101A (en) 1980-02-01 1980-02-01 Process for obtaining human relaxin from fetal membranes

Publications (2)

Publication Number Publication Date
ES498941A0 true ES498941A0 (es) 1982-05-01
ES8203914A1 ES8203914A1 (es) 1982-05-01

Family

ID=22372986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498941A Expired ES8203914A1 (es) 1980-02-01 1981-01-29 Procedimiento para obtener relaxina humana

Country Status (18)

Country Link
US (1) US4267101A (es)
JP (1) JPS56127315A (es)
AR (2) AR227907A1 (es)
AT (1) AT372856B (es)
AU (1) AU540310B2 (es)
BE (1) BE887324A (es)
CA (1) CA1143286A (es)
CH (1) CH647530A5 (es)
DE (1) DE3102487C2 (es)
DK (1) DK44181A (es)
ES (1) ES8203914A1 (es)
FR (1) FR2475047A1 (es)
GB (1) GB2068383B (es)
IL (1) IL61931A (es)
IT (1) IT8147648A0 (es)
NL (1) NL8100243A (es)
SE (1) SE8100614L (es)
ZA (1) ZA81374B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320953A (en) * 1982-08-12 1994-06-14 Howard Florey Institute Of Experimental Physiology And Medicine Process for synthesizing human H1-prorelaxin, H1-relaxin and fusion proteins thereof
EP0101309B1 (en) * 1982-08-12 1991-01-16 Howard Florey Institute Of Experimental Physiology And Medicine Molecular cloning and characterization of a gene sequence coding for human relaxin
US5053488A (en) * 1982-08-12 1991-10-01 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a gene sequence coding for human relaxin
DE3236264A1 (de) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg Verfahren zur gewinnung von relaxin
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
NZ206534A (en) * 1982-12-13 1988-05-30 Florey Howard Inst Molecular cloning and characterisation of gene sequence coding for human relaxin
AU612594B2 (en) * 1986-09-12 1991-07-18 Genentech Inc. Human prorelaxin
WO1989007945A1 (en) * 1988-02-26 1989-09-08 Genentech, Inc. Human relaxin formulation
US6348327B1 (en) * 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US6251863B1 (en) 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
JP4836942B2 (ja) * 2004-04-30 2011-12-14 コーセラ， インコーポレイテッド リラキシンの調節による胎仔の発育の制御のための方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2852432A (en) * 1953-08-11 1958-09-16 Warner Lambert Pharmaceutical Process for purification of relaxin by ion exchange
US2852431A (en) * 1954-05-17 1958-09-16 Warner Lambert Pharmaceutical Process for the extraction and purification of relaxin using trichloracetic acid
US2930737A (en) * 1955-11-15 1960-03-29 Princeton Lab Inc Process for the isolation of relaxin using glacial acetic acid
US2995494A (en) * 1957-12-27 1961-08-08 Ortho Pharma Corp Process for purifying relaxin

Also Published As

Publication number Publication date
AR227907A1 (es) 1982-12-30
JPS6157809B2 (es) 1986-12-09
IT8147648A0 (it) 1981-01-28
CA1143286A (en) 1983-03-22
ATA26281A (de) 1983-04-15
AU6661481A (en) 1981-08-06
AT372856B (de) 1983-11-25
JPS56127315A (en) 1981-10-06
GB2068383B (en) 1983-05-11
NL8100243A (nl) 1981-09-01
US4267101A (en) 1981-05-12
ZA81374B (en) 1982-08-25
DE3102487A1 (de) 1982-01-07
IL61931A (en) 1984-06-29
GB2068383A (en) 1981-08-12
ES8203914A1 (es) 1982-05-01
SE8100614L (sv) 1981-08-02
FR2475047B1 (es) 1983-07-29
CH647530A5 (de) 1985-01-31
BE887324A (fr) 1981-05-14
AU540310B2 (en) 1984-11-08
DK44181A (da) 1981-08-02
DE3102487C2 (de) 1983-06-16
AR227959A1 (es) 1982-12-30
IL61931A0 (en) 1981-02-27
FR2475047A1 (fr) 1981-08-07

Similar Documents

Publication Publication Date Title
DK520980A (da) Hudplade
ES501130A0 (es) Procedimiento de obtencion de mucopolisacaridos
MX151277A (es) Procedimiento mejorado para la obtencion de fosgeno
ES500791A0 (es) Procedimiento para la obtencion de polieterpolioles
AR230264A1 (es) Procedimiento para la obtencion de compuestos de xantato
ES502573A0 (es) Procedimiento para la obtencion de imidazoazoalquenamidas
ES505910A0 (es) Procedimiento para la obtencion de metilformiato
ES498941A0 (es) Procedimiento para obtener relaxina humana
MX156530A (es) Procedimiento mejorado para la obtencion de carboximetilcelulosa
MX7339E (es) Procedimiento mejorado para la obtencion de n- acrilamidas
ES504256A0 (es) Procedimiento para la obtencion de derivados de triazolil- propenol
ES516841A0 (es) Procedimiento para la obtencion de benzofuranonas
DK158034C (da) Spermicidt praeparat til lokal anvendelse
ES526891A0 (es) Procedimiento para la obtencion de benzofuranonas
ES556306A0 (es) Procedimiento para preparar laminina humana
MX155064A (es) Procedimiento de preparacion de metafenilendiaminas
ES498573A0 (es) Procedimiento para la obtencion de nuevos tioles
ES504787A0 (es) Procedimiento para la obtencion de derivados de diaril-imi- dazol
ES502950A0 (es) Procedimiento para la obtencion de mezclas de colorante tri-sazo-acoxi
ES505206A0 (es) Procedimiento para la obtencion de derivados de 1-azolil-bu-tano fluorados
ES507522A0 (es) Procedimiento para la obtencion de 1-fenil-2-triazolil-1-penten-3--oles
AR231990A1 (es) Procedimiento para la preparacion de somatropina carionica humana
ES504736A0 (es) Procedimiento para la obtencion de compuestos poliazahetero-ciclicos
ES510955A0 (es) Procedimiento para la obtencion de metilomelaminas monomeras
ES497763A0 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles